We are live on ! Find out more
IA

IFP Advisors Portfolio holdings

AUM $5.54B
1-Year Est. Return 27.43%
This Fund
S&P 500
This Quarter Est. Return
+4.58%
1 Year Est. Return
+27.43%
3 Year Est. Return
+73.16%
5 Year Est. Return
+63.71%
10 Year Est. Return
AUM
$2.21B
AUM Growth
-$312M
Cap. Flow
-$405M
Cap. Flow %
-18.36%
Top 10 Hldgs %
15.84%
Holding
4,455
New
192
Increased
859
Reduced
2,110
Closed
499

Top Sells

Rank Stock Value
1
PG icon
Procter & Gamble
PG
+$16.1M
2
XOM icon
ExxonMobil
XOM
+$15.9M
3
T icon
AT&T
T
+$12.6M
4
AAPL icon
Apple
AAPL
+$11.8M
5
BP icon
BP
BP
+$10.6M

Sector Composition

Rank Sector Weight
1 Technology 6.22%
2 Financials 5.44%
3 Healthcare 5.11%
4 Consumer Discretionary 4.03%
5 Industrials 3.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EFX icon
2551
Equifax
EFX
$22B
$16K ﹤0.01%
138
-236
-63% -$26.5K
EHC icon
2552
Encompass Health
EHC
$11.5B
$16K ﹤0.01%
406
-80
-16% -$3.04K
FMY
2553
First Trust Mortgage Income Fund
FMY
$48.6M
$16K ﹤0.01%
1,105
-2,652
-71% -$37.7K
FNDC icon
2554
Schwab Fundamental International Small Company Index ETF
FNDC
$3.02B
$16K ﹤0.01%
452
+7
+2% +$248
HASI icon
2555
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$4.95B
$16K ﹤0.01%
671
+2
+0.3% +$48
IMCG icon
2556
iShares Morningstar Mid-Cap Growth ETF
IMCG
$3.94B
$16K ﹤0.01%
474
JOE icon
2557
St. Joe Company
JOE
$3.57B
$16K ﹤0.01%
910
-345
-27% -$6.39K
MAT icon
2558
Mattel
MAT
$4.49B
$16K ﹤0.01%
1,032
-2,004
-66% -$31.8K
MEOH icon
2559
Methanex
MEOH
$4.12B
$16K ﹤0.01%
263
-243
-48% -$12.8K
MTDR icon
2560
Matador Resources
MTDR
$5.73B
$16K ﹤0.01%
504
+118
+31% +$3.24K
MUA icon
2561
BlackRock MuniAssets Fund
MUA
$518M
$16K ﹤0.01%
1,078
-20,959
-95% -$317K
NBIX icon
2562
Neurocrine Biosciences
NBIX
$18.4B
$16K ﹤0.01%
210
+110
+110% +$7.5K
PEN icon
2563
Penumbra
PEN
$12.6B
$16K ﹤0.01%
174
-100
-36% -$9.92K
PEZ icon
2564
Invesco Dorsey Wright Consumer Cyclicals Momentum ETF
PEZ
$22.5M
$16K ﹤0.01%
320
+120
+60% +$5.88K
RGNX icon
2565
Regenxbio
RGNX
$615M
$16K ﹤0.01%
475
+100
+27% +$3.01K
RGLS
2566
DELISTED
Regulus Therapeutics
RGLS
$16K ﹤0.01%
125
RNST icon
2567
Renasant Corp
RNST
$4.05B
$16K ﹤0.01%
380
-1,304
-77% -$54.4K
ECHO
2568
EchoStar
ECHO
$24.9B
$16K ﹤0.01%
332
SPMB icon
2569
State Street SPDR Portfolio Mortgage Backed Bond ETF
SPMB
$7B
$16K ﹤0.01%
620
+2
+0.3% +$52
YHGJ icon
2570
Yunhong Green CTI Ltd
YHGJ
$7.38M
$16K ﹤0.01%
396
TVRD
2571
Tvardi Therapeutics
TVRD
$22.9M
$16K ﹤0.01%
36
+10
+38% +$4.56K
INFN
2572
DELISTED
Infinera Corporation Common Stock
INFN
$16K ﹤0.01%
2,584
HSTO
2573
DELISTED
Histogen Inc. Common Stock
HSTO
$16K ﹤0.01%
17
-11
-39% -$10.2K
AXE
2574
DELISTED
Anixter International Inc
AXE
$16K ﹤0.01%
215
+55
+34% +$4.05K
YMLI
2575
DELISTED
VanEck Vectors High Income Infrastructure MLP ETF
YMLI
$16K ﹤0.01%
1,213
+23
+2% +$308

Similar funds

IFP Advisors's Q4 2017 Portfolio in Review

As of Q4 2017, IFP Advisors held 4,455 positions worth $2.21B, down 12% from $2.52B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

IFP Advisors withdrew a net $405M in Q4 2017, closing 499 positions and reducing 2,110 holdings. Its most notable exit was ProShares Large Cap Core Plus, an estimated $2.47M position sold in full.

By sector, the portfolio is most concentrated in Technology at 6.2% of assets, up from 6.2% a quarter earlier, followed by Financials and Healthcare.

Against the trend, IFP Advisors opened a new position in DuPont de Nemours worth $4.1M.

  • IFP Advisors's largest Q4 2017 buy was DuPont de Nemours: 22,718 shares worth $4.1M.
  • IFP Advisors added most to iShares Biotechnology ETF in Q4 2017, an estimated $5.08M increase.
  • IFP Advisors's biggest Q4 2017 reduction was Procter & Gamble, cutting an estimated $16.1M.
  • IFP Advisors fully exited ProShares Large Cap Core Plus in Q4 2017, selling an estimated $2.47M.
  • IFP Advisors's ten largest holdings make up 16% of its $2.21B portfolio in Q4 2017.
  • IFP Advisors opened 192 new positions and closed 499 in Q4 2017.
  • IFP Advisors's portfolio value fell 12% quarter-over-quarter to $2.21B.

Based on IFP Advisors's 13F filing for Q4 2017, filed 24 Jan 2018.